Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45